Form 4 for SOPH SOPHiA GENETICS SA
Accepted 2026-08-26 16:03:08 ET · period of report 2026-08-19 · accession 0001840706-26-000298 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-08-26 16:03 | 2026-08-19+ | SOPH | Verma Abhimanyu | CTO | S - Sale | $8.50 | -10.0K | 172.2K | -5% | -$85.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-08-19 | S | D | 5,000 | $8.20 | 177,171 | D | — | — | (F1) Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). |
| 2 | Common | Ordinary Shares | 2026-08-24 | S | D | 5,000 | $8.80 | 172,171 | D | — | — | (F1) Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). |